CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

174 hedge funds and large institutions have $1.86B invested in Celldex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 48 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
-2
Holders Change %
-1.14%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
66
Reduced
48
Closed
36
Calls
$24.9M
Puts
$17.1M
Net Calls
+$7.83M
Net Calls Change
-$17.5M

Top Buyers

1
JFG
1
Jefferies Financial Group
New York
$60.4M
2
KCM
2
Kynam Capital Management
New Jersey
$128M
3
DTC
3
Deep Track Capital
Connecticut
$38.9M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$63.6M
5
Morgan Stanley
5
Morgan Stanley
New York
$34M

Top Sellers

1
CC
1
Commodore Capital
New York
$0
2
Jennison Associates
2
Jennison Associates
New York
$0
3
LGM
3
Logos Global Management
California
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$123M
5
PCH
5
Polar Capital Holdings
United Kingdom
$39.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
AAP
201
Arax Advisory Partners
Colorado
– -$4.73K -139 Closed
QT
202
Quantbot Technologies
New York
– -$3.23K -95 Closed
VCM
203
Versant Capital Management
Arizona
– -$3.13K -92 Closed
CFD
204
Creative Financial Designs
Indiana
– -$2.82K -83 Closed
Bessemer Group
205
Bessemer Group
New Jersey
– -$2K -60 Closed
BTI
206
Blue Trust Inc
Georgia
– -$2.18K -59 Closed
UB
207
UMB Bank
Missouri
– -$68 -2 Closed
AssetMark Inc
208
AssetMark Inc
California
– -$34 -1 Closed
5 6 7 8
9